Abstract
Two squalene derivatives, trisnorsqualene cyclopropylamine and trisnorsqualeneN-methylcyclopropylamine, were synthesized and tested for inhibition of lanosterol and squalene epoxide formation from squalene in rat hepatic microsomes, and for the inhibition of cholesterol syntheses in human cultured hepatoblastoma (HepG2) cells. Trisnorsqualene cyclopropylamine inhibited [3H]-squalene conversion to [3H]squalene epoxide in microsomes (IC50=5.0 μM), indicating that this derivative inhibited squalene mono-oxygenase. Trisnorsqualenen-methylcyclopropylamine inhibited [3H]squalene conversion to [3H]lanosterol (IC50=12.0 μM) and caused [3H]-squalene epoxide to accumulate in microsomes, indicating that this derivative inhibited 2,3-oxidosqualene cyclase. Cholesterol biosynthesis from [14C]acetate in HepG2 cells was inhibited by both derivatives (IC50=1.0 μM for trisnorsqualene cyclopropylamine; IC50=0.5 μM for trisnorsqualeneN-methylcyclopropylamine). Cells incubated with trisnorsqualene cyclopropylamine accumulated [14C]squalene, while cells incubated with trisnorsqualeneN-methylcyclopropylamine accumulated [14C]squalene epoxide and [14C]squalene diepoxide. The concentration range of inhibitor which caused these intermediates to accumulate coincided with that which inhibited cholesterol synthesis. The results indicate that cyclopropylamine derivatives of squalene are effective inhibitors of cholesterol synthesis, and that substitutions at the nitrogen affect enzyme selectivity and thus the mechanism of action of the compounds.
Similar content being viewed by others
Abbreviations
- FBS:
-
fetal bovine serum
- HBSS:
-
Hanks buffered salt solution
- HMG-CoA:
-
3-hydroxy-3-methylglutaryl-coenzyme A
- HPLC:
-
high-performance liquid chromatography
- LPDS:
-
lipoprotein-deficient bovine serum
- MEM:
-
minimal essential medium
References
Tobert, J.A., Bell, G.D., Birtwell, J., James, I., Kukovetz, W.R., Pryor, J.S., Buntinx, A., Holmes, I.B., Chao, Y.S., and Bolognese, J.A. (1982)J. Clin. Invest. 69, 913–919.
Alberts, A.W., Chen, J., Kuron, G., Hunt, V., Juff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schoberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J., and Springer, J. (1980)Proc. Natl. Acad. Sci. USA 77, 3957–3961.
Duriatti, A., Bouvier-Navé, P., Benveniste, P., Schuber, F., Delprino, L., Balliano, G., and Cattel, L. (1985)Biochem. Pharmacol. 34, 2765–2785.
Cattel, L., Ceruti, M., Viola, F., Delprino, L., Balliano, G., Duriatti, A., and Bouvier-Navé, P. (1986)Lipids 21, 31–38.
Balliano, G., Viola, F., Ceruti, M., and Cattel, L. (1988)Biochim. Biophys. Acta 959, 9–19.
Sen, S.E., and Prestwich, G.D. (1989)J. Am. Chem. Soc. 111, 1508–1510.
Ceruti, M., Viola, F., Grosa, G., Balliano, G., Delprino, L., and Cattel, L. (1988)J. Chem. Res. (S),1, 18–19.
Sen, S.E., and Prestwich, G.D. (1989)J. Am. Chem. Soc. 111, 8761–8762.
Panini, S.R., Sexton, R.C., and Rudney, H. (1984)J. Biol. Chem. 259, 7767–7771.
Goldstein, J.L., and Brown, M.S. (1990)Nature 343, 425–430.
Saat, Y.A., and Bloch, K. (1976)J. Biol. Chem. 251, 5155–5160.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–275.
Tullman, R.H., and Hanzlik, R.P. (1984)Drug Metabol. Rev. 15, 1163–1182.
Narula, A., Rahier, A., Benveniste, P., and Schuber, F. (1981)J. Am. Chem. Soc. 103, 2408–2409.
Taton, M., Benveniste, P., and Rahier, A. (1987)Pure & Appl. Chem. 59, 287–294.
Rahier, A., Bouvier, P., Cattel, L., Narula, A., and Benveniste, P. (1983)Biochem. Soc. Trans. 11, 537–543.
Author information
Authors and Affiliations
About this article
Cite this article
Van Sickle, W.A., Angelastro, M.R., Wilson, P. et al. Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture. Lipids 27, 157–160 (1992). https://doi.org/10.1007/BF02536171
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536171